Leerink Partnrs Lowers Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Analysts at Leerink Partnrs reduced their Q2 2025 earnings per share estimates for Henry Schein in a report released on Tuesday, February 25th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings per share of $1.23 for the quarter, down from their previous estimate of $1.24. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein's Q4 2025 earnings at $1.29 EPS, FY2025 earnings at $4.92 EPS, FY2026 earnings at $5.48 EPS and FY2027 earnings at $6.05 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. During the same period in the previous year, the business posted $0.66 earnings per share. The company's revenue for the quarter was up 5.8% on a year-over-year basis.

Other research analysts have also recently issued reports about the company. Barrington Research reaffirmed an "outperform" rating and set a $90.00 price objective on shares of Henry Schein in a research report on Wednesday. Mizuho started coverage on Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective on the stock. Wells Fargo & Company started coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective on the stock. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and lifted their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Stock Performance

Shares of HSIC stock traded up $0.05 during trading hours on Thursday, reaching $72.17. 11,190,666 shares of the company traded hands, compared to its average volume of 1,992,676. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market cap of $9.00 billion, a P/E ratio of 29.70, a P/E/G ratio of 2.13 and a beta of 0.91. The firm has a 50-day moving average price of $74.39 and a 200 day moving average price of $72.45.

Institutional Trading of Henry Schein

Hedge funds have recently modified their holdings of the company. Clarkston Capital Partners LLC raised its holdings in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock worth $101,900,000 after acquiring an additional 71,560 shares in the last quarter. Nuance Investments LLC raised its holdings in Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after buying an additional 414,748 shares during the period. Olstein Capital Management L.P. raised its holdings in Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after buying an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Henry Schein during the 3rd quarter valued at $515,000. Finally, Equitable Trust Co. purchased a new stake in Henry Schein during the 4th quarter valued at $417,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.